{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:24:21Z","timestamp":1784366661455,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Recent advancements in proteomics have shown promise in identifying biomarkers for various cancers. Our study is the first to compare the serum proteomes of intrahepatic cholangiocarcinoma (iCCA) with cirrhosis (CIR), primary sclerosing cholangitis (PSC), and hepatocellular carcinoma (HCC), aiming to identify a proteomic signature that can effectively distinguish among these conditions. Utilizing high-throughput mass spectrometry on serum samples, we identified 845 proteins, of which 646 were suitable for further analysis. Unique clustering patterns were observed among the five groups, with significant proteomic differences. Our key findings include: S100 calcium-binding protein A9 (S100A9) and haptoglobin (HP) were more abundant in iCCA, while intercellular adhesion molecule 2 (ICAM2) was higher in HCC. Serum amyloid A1 (SAA1) and A4 (SAA4) emerged as potential biomarkers, with SAA1 significantly different in the iCCA vs healthy controls (HC) comparison, and SAA4 in the HCC vs HC comparison. Elevated levels of vascular cell adhesion molecule 1 (VCAM-1) in HCC suggested its potential as a differentiation and diagnostic marker. Angiopoietin-1 receptor (TEK) also showed discriminatory and diagnostic potential in HCC. ELISA validation corroborated mass spectrometry findings. Our study underscores the potential of proteomic profiling in distinguishing iCCA from other liver conditions and highlights the need for further validation to establish robust diagnostic biomarkers.<\/jats:p>","DOI":"10.3389\/fphar.2024.1440985","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T09:49:00Z","timestamp":1725270540000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration"],"prefix":"10.3389","volume":"15","author":[{"given":"Lavinia Patricia","family":"Mocan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Grapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rare\u0219","family":"Cr\u0103ciun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Ecaterina","family":"Pralea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Uif\u0103lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea Maria","family":"Soporan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena Maria","family":"Mure\u0219an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Iacobescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Al Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Mihaela","family":"Mihu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Sp\u00e2rchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Mocan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adela","family":"Iuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","article-title":"GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis","volume":"18","author":"Best","year":"2020","journal-title":"Clin. Gastroenterology Hepatology Official Clin. Pract. J. Am. Gastroenterological Assoc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3748\/wjg.v27.i27.4453","article-title":"Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma","volume":"27","author":"Choi","year":"2021","journal-title":"World J. Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/ijc.34356","article-title":"Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer","volume":"152","author":"Christensen","year":"2023","journal-title":"Int. J. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J. Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/path.1711770407","article-title":"The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium","volume":"177","author":"Fox","year":"1995","journal-title":"J. Pathology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.30699\/IJP.20201.138489.2512","article-title":"Annexin expression in cholangiocarcinoma, and metastatic pancreatic ductal adenocarcinoma \u2018is it Be helpful for differential diagnosis of these tumors in the liver?","volume":"16","author":"Geramizadeh","year":"2021","journal-title":"Iran. J. Pathology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3748\/wjg.v10.i14.2014","article-title":"Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma","volume":"10","author":"Ho","year":"2004","journal-title":"World J. Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.18632\/oncotarget.26566","article-title":"Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer","volume":"10","author":"Ignacio","year":"2019","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cca.2017.12.008","article-title":"Plasma protein profiling of patients with intraductal papillary mucinous neoplasm of the pancreas as potential precursor lesions of pancreatic cancer","volume":"477","author":"Ilies","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J. Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jss.2020.03.018","article-title":"The prognostic impact of leucine-rich \u03b1-2-glycoprotein-1 in cholangiocarcinoma and its association with the IL-6\/TGF-\u03b21 Axis","volume":"252","author":"Jin","year":"2020","journal-title":"J. Surg. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"72","author":"Job","year":"2020","journal-title":"Hepatol. Baltim. Md"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1023\/a:1018818801824","article-title":"Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis","volume":"42","author":"Kaplanski","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"29934","DOI":"10.1021\/acsomega.2c02926","article-title":"Proteome multimarker panel for the early detection of hepatocellular carcinoma: multicenter derivation, validation, and comparison","volume":"7","author":"Kim","year":"2022","journal-title":"ACS Omega"},{"key":"B16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J. Hepatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12032-016-0829-6","article-title":"Identification of key pathways and genes in colorectal cancer using bioinformatics analysis","volume":"33","author":"Liang","year":"2016","journal-title":"Med. Oncol. N. Lond. Engl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00432-021-03876-0","article-title":"The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors","volume":"148","author":"Lin","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"16966","DOI":"10.3390\/ijms242316966","article-title":"Unveiling distinct proteomic signatures in complicated crohn\u2019s disease that could predict the disease course","volume":"24","author":"Lucaciu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3748\/WJG.V28.I15.1508","article-title":"Novel approaches in search for biomarkers of cholangiocarcinoma","volume":"28","author":"Mocan","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13091542","article-title":"The role of immunohistochemistry in the differential diagnosis between intrahepatic cholangiocarcinoma, hepatocellular carcinoma and liver metastasis, as well as its prognostic value","volume":"13","author":"Mocan","year":"2023","journal-title":"Diagnostics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1134\/S1990750821030069","article-title":"Haptoglobin as a biomarker","volume":"15","author":"Naryzny","year":"2021","journal-title":"Biochem. Mosc. Suppl. Ser. B Biomed. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis","volume":"95","author":"Patel","year":"2000","journal-title":"Am. J. Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/1996\/129325","article-title":"Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases","volume":"13","author":"Pirisi","year":"1996","journal-title":"Dis. Markers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A\u2013a review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol. Med. Camb. Mass.)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/j.gastro.2012.12.029","article-title":"Nuclear \u03b11-antichymotrypsin promotes Chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells","volume":"144","author":"Santamaria","year":"2013","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43066-021-00101-y","article-title":"Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients","volume":"11","author":"Serag","year":"2021","journal-title":"Egypt. Liver J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib Hashem","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1007\/s11605-013-2182-9","article-title":"A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma","volume":"17","author":"Shi","year":"2013","journal-title":"J. Gastrointest. Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1535-7163.MCT-15-0069","article-title":"Heat shock protein 90 is a potential therapeutic target in cholangiocarcinoma","volume":"14","author":"Shirota","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"188760","DOI":"10.1016\/j.bbcan.2022.188760","article-title":"Unfolding the cascade of SERPINA3: inflammation to cancer","volume":"1877","author":"Soman","year":"2022","journal-title":"Biochimica Biophysica Acta (BBA) - Rev. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100786","DOI":"10.1016\/j.mcpro.2024.100786","article-title":"Promises and challenges of populational proteomics in health and disease","volume":"100786","author":"Sun","year":"2024","journal-title":"Mol. and Cell. Proteomics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1108004","DOI":"10.3389\/fgene.2023.1108004","article-title":"Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2004.01.027","article-title":"Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma","volume":"40","author":"Torimura","year":"2004","journal-title":"J. Hepatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12929-019-0599-5","article-title":"Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma","volume":"27","author":"Voigtl\u00e4nder","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201600356","article-title":"Exploring the expression bar code of SAA variants for gastric cancer detection","volume":"17","author":"Wu","year":"2017","journal-title":"Proteomics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1440-1746.1999.01857.x","article-title":"Analysis of adhesion molecules in patients with idiopathic portal hypertension","volume":"14","author":"Yamaguchi","year":"1999","journal-title":"J. Gastroenterology Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","article-title":"Complex roles of CAMP-PKA-CREB signaling in cancer","volume":"9","author":"Zhang","year":"","journal-title":"Exp. Hematol. and Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"","journal-title":"J. Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.3748\/wjg.v26.i35.5287","article-title":"Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma","volume":"26","author":"Zhang","year":"","journal-title":"World J. Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1200\/JCO.2011.38.2697","article-title":"Plasma MicroRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma","volume":"29","author":"Zhou","year":"2011","journal-title":"J. Clin. Oncol. Official J. Am. Soc. Clin. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.3892\/ol.2019.11025","article-title":"Expression levels and prognostic values of annexins in liver cancer","volume":"18","author":"Zhuang","year":"2019","journal-title":"Oncol. Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"809225","DOI":"10.3389\/fphar.2021.809225","article-title":"Research progress on leucine-rich alpha-2 glycoprotein 1: a review","volume":"12","author":"Zou","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1440985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T09:49:09Z","timestamp":1725270549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1440985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":47,"alternative-id":["10.3389\/fphar.2024.1440985"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1440985","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"article-number":"1440985"}}